China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of Oxycodone/Naloxone Sustained-Release Tablets on Progression-Free Survival in Patients with Cancer Pain'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132789
Registration Time: 2026/09/18
Type: Interventional study
Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340249
Published by HT Digital Content Services with permission from Health Daily Digest....